Ameris Bancorp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Ameris Bancorp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Selling and marketing	4.18	5.13	5.57	7.93	8.05	8.43	12	11.6	12.6	12
Interest expense	19.7	34.2	69.9	131	88.8	47.8	92.9	445
Pre-tax income	105	124	151	212	340	496	453	357	476	534
Income tax	33.1	50.7	30.5	50.1	78.3	119	107	87.8	117	122
Net income	72.1	73.5	121	161	262	377	347	269	359	412
EPS, basic	2.10	2.00	2.81	2.76	3.78	5.43	5.01	3.90	5.21	6.02
EPS, diluted	2.08	1.98	2.80	2.75	3.77	5.40	4.99	3.89	5.19	6.00
Shares, basic (weighted)	34.3	36.8	43.1	58.5	69.3	69.4	69.2	69	68.8	68.4
Shares, diluted (weighted)	34.7	37.1	43.2	58.6	69.4	69.8	69.4	69.1	69.1	68.7
Dividend per share	0.30	0.40	0.40	0.50	0.60	0.60	0.60	0.60	0.65	0.80

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	198	331	680	622	2,117	4,065	1,118	1,167	1,220	1,089
Property, plant and equipment	121	118	145	233	223	225	220	216	209	213
Lease right-of-use assets				39.3	73.7	56.1	56.3	49.9	45.1	42.2
Goodwill	126	126	503	932	928	1,013	1,016	1,016	1,016	1,016
Intangible assets	17.4	13.5	58.7	91.6	72	126	106	87.9	70.8	54.8
Total assets	6,892	7,856	11,444	18,243	20,439	23,858	25,053	25,204	26,262	27,516
Total liabilities	6,246	7,052	9,987	15,773	17,792	20,892	21,856	21,777	22,511	23,440
Paid-in capital	410	508	1,052	1,907	1,913	1,925	1,935	1,945	1,959	1,971
Retained earnings	214	273	377	508	672	1,006	1,311	1,540	1,853	2,210
Treasury stock	-13.6	-14.5	-16.6	-35	-43	-52.4	-74.8	-95.2	-103	-187
Other comprehensive income	-1.06	-1.28	-4.83	18	33.5	15.6	-46.5	-35.9	-30.1	8.31
Shareholders' equity	646	804	1,456	2,470	2,647	2,966	3,197	3,427	3,752	4,076
Total equity	646	804	1,456	2,470	2,647	2,966	3,197	3,427	3,752	4,076
Total liabilities and equity	6,892	7,856	11,444	18,243	20,439	23,858	25,053	25,204	26,262	27,516

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	72.1	73.5	121	161	262	377	347	269	359	412
Depreciation and amortization	9.52	9.2	10	13.1	15.8	17.2	41	34.6	36.8	29.7
Stock-based compensation	2.26	3.32	6.24	3.42	3.81	7.95	6.71	9.95	13.4	12.7
Deferred income tax	0.85	12.4	1.37	22.8	-7.93	38.4	-35.7	-20.5	-20.1	-10.6
Cash from operations	-69.8	-62.6	-109	-940	798	9.14	1,062	569	154	390
Capital expenditures	-11	-3.76	-10	-11.6	-18.1	-25.4	-13.6	-17.5	-13.5	-20.5
Acquisitions						-127	-14	0	0
Purchases of investments	-201	-113	-291	-219	0	0	-1,172	-30.5	-693	-1,015
Sales and maturities of investments	76	115	152	266	435	365	187	142	435	493
Cash from investing	-803	-667	-53.3	-487	-1,201	-421	-4,875	-338	-847	-1,303
Stock issued	0	88.7	0	0	2.26	4.53	2.8	0.48	0	0
Share buybacks	-1.23	-0.89	-2.06	-18.4	-8	-9.44	-22.4	-20.3	-7.95	-82.9
Dividends paid	-8.58	-14.7	-16.4	-24.7	-41.7	-41.8	-41.6	-41.6	-41.5	-55.3
Cash from financing	680	862	511	1,370	1,898	2,359	866	-182	746	781
Net change in cash	-192	132	349	-57.7	1,495	1,947	-2,947	49.2	53.1	-131
Free cash flow	-80.7	-66.3	-119	-952	780	-16.3	1,049	551	141	370
Interest paid	19.2	32.5	67.5	125	94.8	49	86.6	418	540	462
Income taxes paid	40.6	38.9	20	35.9	98.6	71.8	134	105	106	156

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $82.29 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Effective tax rate	22.4%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	9.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	1.3%	Net income / average total assets.

Growth

Metric	Value	How it is calculated
Net income growth, 1y	14.9%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	6.0%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	9.5%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	15.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	6.3%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	9.7%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	153.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-28.4%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-13.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	162.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-29.4%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-13.9%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	23.1%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	10.1%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	5.9%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	8.6%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	8.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	9.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	4.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	3.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Liabilities / assets	85.6%	Total liabilities / total assets.
Goodwill and intangibles / assets	3.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$3.07B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
FCF conversion	138.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	4.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.61	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
FCF per share	$7.78	Free cash flow / diluted weighted shares.
Operating cash flow per share	$8.17	Cash from operations / diluted weighted shares.
Book value per share	$60.96	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$45.83	Tangible book value / shares outstanding.
Cash per share	$17.84	(Cash + short-term investments) / shares outstanding.
Payout ratio	14.6%	Dividends paid / net income, when net income is positive.
Dividends / FCF	10.5%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	29.2%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$5.52B	Share price x shares outstanding.
Enterprise value	$4.33B	Market cap + total debt - cash - short-term investments.
P/E	14.7x	Market cap / net income. Only when net income is positive.
P/B	1.35x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.80x	Market cap / tangible book value, when positive.
P/FCF	10.6x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	10.1x	Market cap / cash from operations, when positive.
EV/FCF	8.29x	Enterprise value / free cash flow, when both are positive.
FCF yield	9.5%	Free cash flow / market cap.
Earnings yield	6.8%	Net income / market cap (the inverse of P/E).
Dividend yield	1.0%	Dividends paid over the period / market cap.
Shareholder yield	3.8%	(Dividends paid + share buybacks) / market cap.
PEG	2.32x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

Was Ameris Bancorp profitable in fiscal 2025?

Yes. Net income was $412.2M, a net margin of -.

How much free cash flow did Ameris Bancorp generate in fiscal 2025?

Cash from operations of $390.2M minus capital expenditures of $20.5M left free cash flow of $369.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Ameris Bancorp